Pharmacy Deserts Also Face Social Vulnerability, Lack of Health Care Providers
By Lori Solomon HealthDay Reporter
TUESDAY, Aug. 27, 2024 -- Counties with high pharmacy desert densities also face social vulnerability and health care provider shortages, according to a research letter published online Aug. 23 in JAMA Network Open.
Giovanni Catalano, M.D., from The Ohio State University Wexner Medical Center in Columbus, and colleagues examined if pharmacy deserts disproportionately affect individuals living in U.S. regions with low practitioner supply and high social vulnerability. The analysis included communities located ≥10 miles from the nearest retail pharmacy based on the TelePharm Map, with Social Vulnerability Index (SVI) and primary care provider (PCP) data obtained from the Agency for Toxic Substances and Disease Registry.
The researchers found that among 3,143 U.S. counties, 46 percent had at least one pharmacy desert, of which 56.5 percent were categorized as having low and 43.5 percent as having high pharmacy desert density. Compared with counties with low pharmacy desert density, counties with a high pharmacy desert density had a higher SVI. Similarly, areas with a high pharmacy desert density also had lower median PCP density compared with regions with low or no pharmacy desert density. When controlling for age and sex, both high SVI (odds ratio, 1.35) and low PCP density (odds ratio, 2.27) were associated with a higher likelihood for a county to have a high pharmacy desert density.
"These findings highlight how disparities compound to create barriers to access basic health care," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
IDSA: EHR Order Set Reduces Antibiotic Duration in Children With AOM
THURSDAY, Oct. 17, 2024 -- Implementation of an electronic health record (EHR) order set increases compliance with the recommended duration of prescribed antibiotics for children...
In Utero Exposure to COVID-19 Not Tied to Later Neurodevelopmental Issues
THURSDAY, Oct. 17, 2024 -- Exposure to maternal COVID-19 is not associated with abnormal neurodevelopmental screening results through 24 months postpartum, according to a study...
Racial, Gender, Socioeconomic Disparities Seen in Teen Alcohol, Drug Screening
THURSDAY, Oct. 17, 2024 -- Rates of biochemical alcohol and drug screening are disproportionately higher among adolescent trauma patients who are from racial and ethnic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.